Human Genome Epidemiology Literature Finder
Filtered By: |
Previous |
Records 1 - 5 (of 5 Records) |
Query Trace: Head and Neck Neoplasms and MMP2[original query] |
---|
The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral oncology 2006 Mar 42 (3): 257-67. O-Charoenrat Pornchai, Khantapura Patchari |
Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Mutagenesis 2010 Jul 25 (4): 371-9. Peng Bo, Cao Lihuan, Ma Xiaopin, Wang Wenzhang, Wang Dan, Yu Lo |
Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. PloS one 2013 8 (4): e62023. Zhang Caiyun, Li Chao, Zhu Minhui, Zhang Qingzhou, Xie Zhenghua, Niu Gang, Song Xicheng, Jin Lei, Li Guojun, Zheng Honglia |
Detection of nasopharyngeal carcinoma susceptibility with single nucleotide polymorphism analysis using next-generation sequencing technology. Oncotarget 2017 (32): 52708-52723. Wu Mu-Yun, Huang Shu-Jing, Yang Fan, Qin Xin-Tian, Liu Dong, Ding Ying, Yang Shu, Wang Xi-Che |
Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy. Cancer chemotherapy and pharmacology 2021 Jul . Duran Goretti, Cruz Raquel, Aguín Santiago, Barros Francisco, Giráldez José María, Bernárdez Beatriz, Zarra Irene, López-López Rafael, Carracedo Ángel, Lamas María Jes |
- Page last reviewed:Feb 1, 2024
- Content source: